Research involving ϲʹ with relevance full recovery for Covid-19 patients cited by European Parliament
Research by Professor Dyfrig Hughes of the Centre for Health Economics and Medicines Evaluation in School of Health Sciences into the economic impact of chronic fatigue syndrome (CFS) - also known as myalgic encephalomyelitis (ME) – was published recently in the journal Healthcare. It has been picked up and cited by the European Parliament in their decision to support increased biomedical research funding for ME/CFS.
Prof Hughes, delighted that this research was having an impact on the European stage commented:
“The research was undertaken as part of the European Network on ME/CFS (EUROMENE) and identified that the annual burden of ME/CFS in Europe could be in the region of €40 bn. The report made recommendations for future research directed at assessing the economic impacts of ME/CFS. This is particularly important in relation to the current global pandemic given the likely high incidence of post-viral fatigue syndrome in Covid-19 survivors.”